FTSE All-Share
5.317,66
PKT
+0,70
PKT
+0,01
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.09.17 | Barclays Sell | Goldman Sachs Group Inc. | |
| 15.09.17 | Barclays overweight | JP Morgan Chase & Co. | |
| 15.09.17 | BP buy | UBS AG | |
| 14.09.17 | National Grid overweight | Morgan Stanley | |
| 14.09.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 14.09.17 | National Grid overweight | JP Morgan Chase & Co. | |
| 14.09.17 | National Grid Sell | Deutsche Bank AG | |
| 14.09.17 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.09.17 | GSK buy | HSBC | |
| 13.09.17 | Prudential Hold | Société Générale Group S.A. (SG) | |
| 13.09.17 | AstraZeneca overweight | Barclays Capital | |
| 13.09.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 13.09.17 | Diageo Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.09.17 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 12.09.17 | Diageo Outperform | Credit Suisse Group | |
| 12.09.17 | Vodafone Group buy | Deutsche Bank AG | |
| 12.09.17 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 12.09.17 | Rio Tinto buy | Deutsche Bank AG | |
| 12.09.17 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.09.17 | Prudential buy | Goldman Sachs Group Inc. | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 11.09.17 | Vodafone Group buy | Jefferies & Company Inc. | |
| 11.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.09.17 | AstraZeneca Neutral | BNP PARIBAS | |
| 11.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 11.09.17 | Diageo overweight | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca buy | Deutsche Bank AG | |
| 11.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 11.09.17 | AstraZeneca Neutral | Credit Suisse Group | |
| 11.09.17 | AstraZeneca Reduce | HSBC | |
| 11.09.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.09.17 | GSK Underweight | Morgan Stanley | |
| 08.09.17 | GSK Neutral | Citigroup Corp. | |
| 08.09.17 | Prudential overweight | Barclays Capital | |
| 08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.09.17 | BT Group Outperform | Macquarie Research | |
| 07.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 07.09.17 | Unilever Neutral | JP Morgan Chase & Co. |